VALN Stock Price Chart
VALN Financial
Valneva SE
$5.65
1.98%
$0.11
At close: Aug 13, 16:00:00 GMT-4
$6.95
23.03%
$1.3
Pre-market: Aug 14, 05:31:54 GMT-4
Back
Valneva SE (VALN) Financial
Key Stats
Prev.Close
$5.54
Open
$5.45
Day's Range
$5.45 - $6.95
52 week range
$4.75 - $12.25
Volume
29.2K
Avg.Volume
29.7K
Dividend yield
--
EPS (TTM)
-1.85
Market Cap
$709.8M
What is Valneva SE?
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. The company is headquartered in Saint-Herblain, Pays De La Loire and currently employs 694 full-time employees. The company went IPO on 2007-06-28. The firm's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The firm has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The firm is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.
